logo
logo

Summit Partners has invested in Dreampath Diagnostics to drive digital transformation in anatomical pathology. This growth investment will enhance Dreampath's global expansion and product portfolio.

Jul 14, 20255 days ago
StrasbourgBiotechnologyHealth Care

Investors

Summit Partners

Description

Summit Partners announced a growth investment in Dreampath Diagnostics, aimed at supporting the company's global growth and commercial reach. Dreampath specializes in digitizing workflows in anatomical pathology laboratories. The investment will enable the company to scale operations and expand its product offerings. Pathology labs can rely on Dreampath's automated solutions for efficient sample archiving and retrieval.

Company Information

Company

Dreampath Diagnostics

Location

Strasbourg, Grand Est, France

About

Dreampath Diagnostics is a global leader of digital sample management systems for anatomical pathology laboratories. The company’s patented solutions combine purpose-built scanners, software and consumables to enable automated and error-free archiving and rapid retrieval of tissue samples, helping labs accelerate diagnostics, improve accuracy, and compliance. Dreampath’s systems are used in leading labs and institutions across nearly 40 countries.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Related People